HIF-2 Inhib Generic Drug for RCC

Belzutifan is a medicine that blocks something called HIF-2 alpha. It’s used to treat a type of kidney cancer called VHL-RCC. It works by cutting down the signal that makes tumors feel starved for oxygen.

You can get these in 40 mg tablets. The doctors usually suggest taking 120 mg of it every day. Each bottle holds 90 of these tablets with a coating.

Belzutifan stops a protein called HIF-2α, which helps cells cope with not having enough oxygen. This protein is big in how cancer cells grow and blood vessels form in RCC. By doing this, Belzutifan’s thought to slow down the growth and make cancer cells live less.

These tablets are made so you can take one a day, making it easier for people. You can take this tablet with or without eating, just don’t have it with milk ’cause it could mess with how your body takes it in. The 120 mg dose a day they suggest is from studies showing it works, and your doctor might tweak it based on what you need.